Gallery: Providing comprehensive treatment for patients with tuberculosis

MSF is one of the biggest non-governmental providers of tuberculosis (TB) treatment – including for drug-resistant TB – in the world. MSF has TB treatment projects in 24 countries, and in 2015 supported more than 20,000 TB patients on treatment, including 2,000 patients with drug-resistant TB.

Drug-resistant forms of TB are much harder to cure than drug-sensitive TB, as the standard TB drugs don’t work, and the limited treatment available involves long, complex, toxic and expensive treatment regimens. In 2015, just 20 per cent of the 580,000 people newly eligible for multi-drug resistant TB treatment are estimated to have received it.